These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22561482)

  • 1. Reporting bias in industry-supported medication trials presented at the American Psychiatric Association meeting.
    Sen S; Prabhu M
    J Clin Psychopharmacol; 2012 Jun; 32(3):435. PubMed ID: 22561482
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug research: marketing before evidence, sales before safety.
    Klemperer D
    Dtsch Arztebl Int; 2010 Apr; 107(16):277-8. PubMed ID: 20467552
    [No Abstract]   [Full Text] [Related]  

  • 3. Bias in the design, interpretation, and publication of industry-sponsored clinical research.
    Hammerschmidt D
    Minn Med; 2008 Jun; 91(6):46-7. PubMed ID: 18616022
    [No Abstract]   [Full Text] [Related]  

  • 4. Comments on 'The potential for bias in the reporting of industry sponsored clinical trials' by Stephen Pyke et al. and 'Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry sponsored clinical trials' by James Matcham et al. Pharmaceutical Statistics.
    Campbell MJ
    Pharm Stat; 2011; 10(1):80-1. PubMed ID: 21275038
    [No Abstract]   [Full Text] [Related]  

  • 5. Germany launches investigation into human trials scandal.
    Hyde R
    Lancet; 2013 Jul; 382(9887):115-6. PubMed ID: 23858551
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of selective publication on clinical research in pain.
    Rowbotham MC
    Pain; 2008 Dec; 140(3):401-404. PubMed ID: 19004556
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of schizophrenia drugs often favors firm funding study.
    Vendantam S
    Washington Post; 2006 Apr; ():A1, A6. PubMed ID: 16856276
    [No Abstract]   [Full Text] [Related]  

  • 8. Correspondence (letter to the editor): Trend gives cause for concern.
    Maier C; Zenz M
    Dtsch Arztebl Int; 2010 Sep; 107(38):670-1; author reply 673-4. PubMed ID: 20953257
    [No Abstract]   [Full Text] [Related]  

  • 9. Ghostwriters, data manipulation and dollar diplomacy: how drug companies pull the strings in clinical research.
    Berger E
    Ann Emerg Med; 2008 Aug; 52(2):137-9. PubMed ID: 18672488
    [No Abstract]   [Full Text] [Related]  

  • 10. [ACCOMPLISH and the risks with company sponsored clinical trials].
    Furberg C
    Lakartidningen; 2009 Feb 11-17; 106(7):450. PubMed ID: 19350775
    [No Abstract]   [Full Text] [Related]  

  • 11. Commentary: Professional responsibilities.
    Jacobs A
    Pharm Stat; 2011; 10(1):82. PubMed ID: 21275039
    [No Abstract]   [Full Text] [Related]  

  • 12. Yes, industry influence is excessive.
    Shah AA; Finucane TE
    Int Psychogeriatr; 2007 Dec; 19(6):1004-10; discussion 1014-20. PubMed ID: 17711608
    [No Abstract]   [Full Text] [Related]  

  • 13. The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.
    Schott G; Pachl H; Limbach U; Gundert-Remy U; Ludwig WD; Lieb K
    Dtsch Arztebl Int; 2010 Apr; 107(16):279-85. PubMed ID: 20467553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research funding, conflicts of interest, and the meta-methodology of public relations.
    Rampton S; Stauber J
    Public Health Rep; 2002; 117(4):331-9. PubMed ID: 12477914
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative effectiveness reviews and the impact of funding bias.
    Gartlehner G; Fleg A
    J Clin Epidemiol; 2010 Jun; 63(6):589-90. PubMed ID: 20434022
    [No Abstract]   [Full Text] [Related]  

  • 16. Independent medical research.
    van der Meer JW; de Gier AM; van Swaaij WP; Katan MB
    Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759
    [No Abstract]   [Full Text] [Related]  

  • 17. Industry-sponsored clinical research: a broken system.
    Angell M
    JAMA; 2008 Sep; 300(9):1069-71. PubMed ID: 18768418
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychological aspects of gifts from drug companies.
    Tansey M
    JAMA; 2003 Nov; 290(18):2405-6; author reply 2406-7. PubMed ID: 14612470
    [No Abstract]   [Full Text] [Related]  

  • 19. Justice in the application of science: beyond fair benefits.
    London AJ
    Am J Bioeth; 2010 Jun; 10(6):54-6. PubMed ID: 20526976
    [No Abstract]   [Full Text] [Related]  

  • 20. NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward.
    Samson K
    Ann Neurol; 2010 Mar; 67(3):A7-A10. PubMed ID: 20373337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.